Bacillus Calmette–Guérin (BCG) Vaccine Uses, Dosage, Side Effects and more
Bacillus Calmette–Guérin (BCG) Vaccine has been investigated for the treatment of Neoplasms, Bladder Cancer, Neoplasms by Site, Urologic Diseases, and Urologic Neoplasms, among others.
| Trade Name | Bacillus Calmette–Guérin (BCG) Vaccine |
| Generic | BCG vaccine |
| BCG vaccine Other Names | Bacillus calmette-guerin live antigen, unspecified substrain, Bacillus Calmette–Guérin (BCG) vaccine, BCG, BCG vaccine |
| Type | |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Bacillus Calmette–Guérin (BCG) Vaccine is a vaccine indicated in the prevention of tuberculosis and the treatment of non-invasive urothelial bladder cancer.
Bacillus Calmette–Guérin (BCG) Vaccine is also used to associated treatment for these conditions: Non-Invasive Bladder Urothelial Carcinoma, Recurrent Superficial Bladder Cancer, Tuberculosis (TB), Urothelial Carcinoma Recurrent, Carcinoma in situ of urinary bladder
